Nucleotides: Purines, Pyrimidines, Nucleosides, and Nucleotides – Comprehensive Study Notes

Nucleotides: Purines, Pyrimidines, Nucleosides, and Nucleotides – Comprehensive Study Notes

  • This chapter covers the chemistry, structure, and physiological roles of purines and pyrimidines, their nucleosides and nucleotides, and the way these units form polynucleotides (DNA and RNA).
  • Key themes include tautomerism, glycosidic bond geometry (syn vs anti), sugar pucker, phosphorylation states, and the biological implications of these features.

Chemistry of Purines, Pyrimidines, Nucleosides, and Nucleotides

  • Purines and pyrimidines are nitrogen-containing heterocycles that form the bases of nucleotides.

    • Purines are the larger bases (adenine A and guanine G).
    • Pyrimidines are the smaller bases (cytosine C, thymine T, uracil U).

  • Heteroatoms and planarity promote stacking in DNA, aiding duplex stability.

  • Keto–enol and amine–imine tautomerism exist for oxo and amino groups, but under physiological conditions the amino and oxo forms predominate.

  • Exocyclic amino groups (e.g., NH2) are weak bases with pKa around 3–4; under physiological pH, protonation is typically on ring nitrogens (e.g., N1 in adenine, N7 in guanine, N3 in cytosine).

  • Formula reference: tautomeric forms are depicted in Figure 32–2 (not shown here).

  • Nucleosides are N-glycosides: a sugar is attached to a ring nitrogen of a base.

    • Sugar is D-ribose in ribonucleosides, and 2′-deoxy-D-ribose in deoxyribonucleosides.
    • The sugar and base are linked by an α-N-glycosidic bond, typically to N-1 of a pyrimidine or to N-9 of a purine.
    • The sugar atoms are numbered with primed numerals to distinguish them from the base (e.g., 2′, 3′, 5′).

  • Conformers: the heterocyclic N-glycosidic bond restricts rotation, giving syn and anti conformers; anti is the predominant form in most nucleosides/nucleotides, though both occur in nature.

  • Nucleotides are nucleosides with one or more phosphoryl groups:

    • Mononucleotides = nucleosides with a phosphoryl group esterified to a sugar hydroxyl.
    • 3′-Nucleotides have a phosphate on the 3′-OH; 5′-nucleotides have a phosphate on the 5′-OH. Most nucleotides are 5′-nucleotides (the 5′ prefix is usually omitted).
    • Example: UMP and dAMP denote nucleotides with a phosphate on C-5 of the sugar.
    • Higher phosphoryl-content species: diphosphates (e.g., ADP) and triphosphates (e.g., ATP) formed via acid anhydride bonds to the phosphomonoester.
    • Figure references: ATP, its diphosphate, and its monophosphate illustrate these relationships.

  • Syn vs Anti: no rotation about β-N-glycosidic bond; both syn and anti exist, but anti is predominant.

  • Table 32-1 (not reproduced here) lists major purines/pyrimidines along with their nucleoside and nucleotide derivatives. Abbreviations: A, G, C, T, U; d-prefix indicates deoxyribose (e.g., dATP).

  • Figures referenced: Structures of AMP, dAMP, UMP, TMP; ribonucleosides drawn in the syn conformation (for some representations).

  • Modifications of polynucleotides occur in DNA/RNA:

    • 5-methylcytosine (5mC) in bacterial and human DNA.
    • 5-hydroxymethylcytosine (5hmC) in bacterial and viral nucleic acids.
    • N6- and N1-methylated adenine/guanine residues in mammalian mRNAs.
    • Other modified bases include hypoxanthine, xanthine, and uric acid (purine degradation intermediates).
    • Plant-derived methylated xanthine derivatives include caffeine, theophylline, and theobromine.
    • Pseudouridine (ψ) is a C-5–ribose linked to uracil via a C–C bond, formed by rearrangement of UMP in tRNA; methylation by S-adenosylmethionine (SAM) of UMP in preformed tRNA yields thymidine monophosphate (TMP) in RNA.

  • Nucleotides are polyfunctional acids:

    • Primary pKa of the phosphate (–P(=O)(OH)2) group ~1.0; secondary phosphoryl group pKa ~6.2.
    • At physiological pH, nucleotides carry significant negative charge due to deprotonation of phosphate groups.

  • Ultraviolet absorption:

    • Conjugated double bonds of bases absorb UV light; at pH 7.0, common nucleotides absorb near 260 nm; this is used to quantify nucleic acids (absorbance at 260 nm, A260).
    • UV absorption is mutagenic due to induction of chemical modifications in DNA.

  • Nucleotides in metabolism and signaling:

    • ATP, GTP, UTP, CTP and derivatives serve various roles beyond nucleic acid synthesis:
    • ATP: principal energy transducer and a regulator of enzyme activity; allosteric activation/inhibition by ATP, ADP, AMP, and CTP.
    • GTP: allosteric regulator and energy source for protein synthesis; involved in signal transduction.
    • cAMP and cGMP: second messengers in hormonally regulated events and NO signaling.
    • Notable intracellular concentrations: ATP ~ 1 mM; cAMP ~ 1 nM (six orders of magnitude lower than ATP).
    • Adenosine 3′-phosphate-5′-phosphosulfate (APS) serves as sulfate donor for sulfated proteoglycans and drug conjugates; S-adenosylmethionine (SAM) is a methyl group donor.
    • UDP-sugar derivatives participate in sugar epimerizations and biosynthesis of glycogen and related oligosaccharides; UDP-glucuronic acid forms glucuronide conjugates of bilirubin and other drugs.
    • CTP participates in biosynthesis of phosphoglycerides, sphingomyelin, and other substituted sphingosines.
    • Coenzymes often derive from AMP structures (see Table 32-2 for a broader list).

  • Coenzymes and related AMP derivatives (representative examples):

    • 3′,5′-cyclic AMP (cAMP)
    • NAD⁺, NADP⁺
    • FAD (flavin adenine dinucleotide)
    • Coenzyme A (CoA; derived from pantothenate)
    • S-adenosylmethionine (SAM)
    • Coenzymes can carry adenosine monophosphate as a core moiety or be linked to adenosine derivatives.
    • Note: The table in the text (Table 32-2) lists additional coenzymes derived from AMP with their specific R, R′, R″ substituents.

  • Nucleotide triphosphates and energy transfer:

    • Nucleoside triphosphates have high group transfer potential because they contain two anhydride bonds (β–γ and α–β linkages).
    • Standard free energy of hydrolysis for each terminal phosphoryl group is about riangle G^\circ'_{{hyd}} ext{ for each terminal group} \,\approx -7\ \text{kcal/mol} \,(-30\ \text{kJ/mol}).
    • This energy release drives polymerization reactions (e.g., formation of nucleic acids) and other endergonic processes when coupled to the hydrolysis of NTPs.
    • Hydrolysis of the phosphoanhydride bonds is typically coupled to endergonic biosynthetic steps (e.g., polymerization of nucleic acids).

  • Synthetic nucleotide analogs and chemotherapy:

    • Modified purines/pyrimidines or nucleosides/nucleotides are used as anticancer and antiviral agents.
    • Examples of purine/pyrimidine analogs used in cancer chemotherapy include: 5-fluorouracil, 5-iodouracil, 3′-deoxyuridine, 6-thioguanine, 6-mercaptopurine, 5-azauridine, 6-aza- or 5-azacytidine, 8-azaguanine, etc.
    • Allopurinol inhibits purine biosynthesis and xanthine oxidase; cytarabine treats cancer; azathioprine (catabolized to 6-mercaptopurine) is used to suppress immune rejection in transplantation.
    • Figure references: synthetic analogs (Figure 32–13 and Figure 32–14).

  • Non-hydrolyzable nucleotide triphosphate analogs as research tools:

    • Non-hydrolyzable analogs (β-methylene and γ-imino derivatives) allow separation of effects due to phosphoryl transfer from effects due to occupancy of nucleotide-binding sites on enzymes (Figure 32–15).
    • These tools help distinguish regulatory signaling from catalytic transfer.

  • DNA & RNA: Polynucleotides and directional synthesis

    • DNA and RNA are polynucleotides: monomers linked by phosphodiester bonds in a 3′ → 5′ direction.
    • The 5′-phosphoryl group of a mononucleotide can esterify the 3′-OH of the sugar of another nucleotide to form a dinucleotide, establishing the backbone of RNA/DNA.
    • Biologic formation of dinucleotides is not a simple condensation in vivo due to the thermodynamic favorability of hydrolysis; rather, enzymatic catalysis by phosphodiesterases/hydrolases controls turnover.
    • RNA is less stable than DNA largely due to the 2′-OH in RNA, which can act as a nucleophile to aid hydrolysis of the 3′,5′-phosphodiester bond.
    • Posttranslational (posttranscriptional) modifications of nucleotides add structural diversity to RNA:
    • Pseudouridine (ψ) is formed by rearrangement of a UMP in tRNA; this yields a C–C glycosidic linkage instead of the standard β-N-glycosidic bond.
    • TMP (thymidine monophosphate) in RNA can arise via methylation of a UMP in preformed tRNA by SAM.

  • Polynucleotides: Directionality and representation

    • Directionality is 3′ → 5′: all phosphodiester bonds are 3′ → 5′.
    • When written as a sequence, the leftmost base corresponds to the 5′-end, e.g., pTpGpT or TGCATCA, with the 5′-end on the left and the 3′-end on the right.
    • A concise sequence representation GGATC shows bases from 5′ to 3′.
    • The 5′-end is always shown at the left in such representations.

  • Summary of key points (condensed):

    • Under physiologic conditions, amino and oxo tautomers predominate for purines, pyrimidines, and derivatives.
    • Nucleic acids contain A, G, C, T, U and trace amounts of 5-methylcytosine, 5-hydroxymethylcytosine, ψ, and N-methylated heterocycles.
    • Most nucleosides have D-ribose or 2′-deoxy-D-ribose linked to N-1 (pyrimidines) or N-9 (purines) by a β-glycosidic bond, with syn conformers often shown in structural depictions, though anti is predominant in reality.
    • Primed numerals (e.g., 3′, 5′) indicate sugar atoms; monosaccharide phosphorylation states give rise to higher-order nucleotides (di- and triphosphates).
    • Nucleoside triphosphates have high group-transfer potential and are central to energy transduction and biosynthesis.
    • Cyclic nucleotides (cAMP, cGMP) function as intracellular second messengers; GTP participates in protein synthesis and signaling.
    • Chemotherapy uses synthetic nucleotide analogs to inhibit nucleotide metabolism or to be incorporated into nucleic acids, interfering with replication/detection.
    • Non-hydrolyzable nucleotide triphosphate analogs serve as research tools to probe nucleotide signaling and enzyme regulation.

  • Commonly used abbreviations and nomenclature to be comfortable with:

    • A, G, C, T, U as nucleobases.
    • dNTPs denote deoxynucleoside triphosphates (e.g., dATP).
    • The prefix 5′- or 3′- indicates the position of the phosphate group relative to the sugar.
    • The presence of a sugar with a hydroxyl group at 2′ (RNA) vs lack of 2′-OH (DNA) is a key structural difference with functional consequences.

  • Practical conventions (for reading sequences):

    • Representation of nucleotides in DNA/RNA sequences is written left-to-right from 5′ to 3′, with 5′-end on the left.
    • Phosphodiester bonds are oriented 3′ → 5′ along the backbone.

  • Connections to broader topics:

    • The chemistry of nucleotides underpins DNA replication, transcription, and translation, as well as energy metabolism, signaling, and regulation.
    • Posttranscriptional and posttranslational modifications expand the functional repertoire of nucleic acids and cellular regulation.
    • Coenzyme diversity shows how nucleotide-like structures participate in wide-ranging biochemical processes beyond information storage.

  • Selected figures and tables referenced (conceptual):

    • Figure 32-1: Purine and pyrimidine structures and numbering.
    • Figure 32-2: Tautomerism of oxo and amino groups.
    • Figure 32-3: Nucleosides drawn as syn conformers; glycosidic linkage to N-1 (pyrimidines) or N-9 (purines).
    • Figure 32-4: ATP and its diphosphate/triphosphate relationships.
    • Figure 32-5: Syn vs anti conformers for adenosine.
    • Figure 32-6: AMP, dAMP, UMP, TMP structures.
    • Figure 32-7 to 32-9: Uncommon naturally occurring pyrimidines/purines and methylated derivatives (caffeine, theobromine, theophylline).
    • Figure 32-10: cAMP and cGMP structures.
    • Figure 32-11: Adenosine 3′-phosphate-5′-phosphosulfate (APS).
    • Figure 32-12: S-adenosylmethionine (SAM).
    • Figure 32-13 and 32-14: Selected synthetic pyrimidine/purine analogs and cytarabine/azathioprine.
    • Figure 32-15: Non-hydrolyzable nucleotide triphosphate analogs.
    • Table 32-1: Major bases and derivatives (nucleosides and nucleotides).
    • Table 32-2: Coenzymes and related compounds derived from AMP.

  • Quick reference formulas and numbers to memorize:

    riangle G^\circ'{{hyd}}(eta ext{-phosphate}) \,\approx \, -7\ \text{kcal/mol} riangle G^\circ'{{hyd}}( ext{gamma}) \,\approx \, -7\ \text{kcal/mol}

    • pKa(primary phosphoryl group)≈1.0pK_a^{(primary\ phosphoryl\ group)} \approx 1.0
    • pKa(secondary phosphoryl group)≈6.2pK_a^{(secondary\ phosphoryl\ group)} \approx 6.2
    • Nucleotides absorb maximally near  ildeλ=260 nm\ ilde{\lambda} = 260\ \text{nm} at pH 7.0

  • End-of-chapter takeaway:

    • Understanding the structural basis of nucleotides, their dynamic tautomerism, the sugar-base linkage, and the phosphate transfer potential is essential for grasping how nucleic acids are formed, how energy is transduced in metabolism, and how drugs target nucleotide metabolism.

  • Optional connections for exam prep:

    • Be able to draw and name the amino- and oxo-tautomers of purines and pyrimidines and identify the predominant form under physiologic conditions.
    • Draw the principal nucleotides (AMP, CMP, GMP, TMP, UMP) and their deoxy counterparts and indicate the sugar (ribose vs 2′-deoxyribose) and glycosidic bond.
    • Distinguish syn vs anti conformers and specify which predominates for nucleosides in solution.
    • Explain why 3′−5′ phosphodiester bonds confer directionality to DNA/RNA and how the 5′–end is defined in sequence notation.
    • Describe how NTPs provide free energy through hydrolysis of terminal phosphate bonds and how this energy drives polymerization and other biosynthetic processes.
    • List examples of clinically relevant nucleotide analogs and their mechanisms of action (enzyme inhibition vs incorporation into nucleic acids).

  • Note on conventions for studying:

    • Use primed numerals to distinguish sugar atoms (e.g., 2′-H, 3′-OH, 5′-phosphate).
    • When reading sequence representations like pTpGpT or TGCATCA, remember the leftmost base corresponds to the 5′-end and all phosphodiester bonds are 3′→5′.

  • If you need a condensed quick-reference sheet, I can generate a one-page summary with the most essential points (structures, nomenclature, and key energetics) formatted for quick review.